Literature DB >> 15677323

The ups and downs of gene expression and retroviral DNA integration.

Alan Engelman1.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 15677323      PMCID： PMC547887          DOI： 10.1073/pnas.0409587101

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  20 in total

1.  Relationship between retroviral DNA integration and gene expression.

Authors:  J B Weidhaas; E L Angelichio; S Fenner; J M Coffin
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 2.  Integration by design.

Authors:  Suzanne Sandmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-05       Impact factor: 11.205

Review 3.  The roles of cellular factors in retroviral integration.

Authors:  A Engelman
Journal:  Curr Top Microbiol Immunol       Date:  2003       Impact factor: 4.291

4.  HIV-1 integration in the human genome favors active genes and local hotspots.

Authors:  Astrid R W Schröder; Paul Shinn; Huaming Chen; Charles Berry; Joseph R Ecker; Frederic Bushman
Journal:  Cell       Date:  2002-08-23       Impact factor: 41.582

5.  HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells.

Authors:  Peter Cherepanov; Goedele Maertens; Paul Proost; Bart Devreese; Jozef Van Beeumen; Yves Engelborghs; Erik De Clercq; Zeger Debyser
Journal:  J Biol Chem       Date:  2002-10-28       Impact factor: 5.157

6.  Targeting of the yeast Ty5 retrotransposon to silent chromatin is mediated by interactions between integrase and Sir4p.

Authors:  W Xie; X Gai; Y Zhu; D C Zappulla; R Sternglanz; D F Voytas
Journal:  Mol Cell Biol       Date:  2001-10       Impact factor: 4.272

7.  LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1.

Authors:  S Hacein-Bey-Abina; C Von Kalle; M Schmidt; M P McCormack; N Wulffraat; P Leboulch; A Lim; C S Osborne; R Pawliuk; E Morillon; R Sorensen; A Forster; P Fraser; J I Cohen; G de Saint Basile; I Alexander; U Wintergerst; T Frebourg; A Aurias; D Stoppa-Lyonnet; S Romana; I Radford-Weiss; F Gross; F Valensi; E Delabesse; E Macintyre; F Sigaux; J Soulier; L E Leiva; M Wissler; C Prinz; T H Rabbitts; F Le Deist; A Fischer; M Cavazzana-Calvo
Journal:  Science       Date:  2003-10-17       Impact factor: 47.728

8.  Specificity of interaction of INI1/hSNF5 with retroviral integrases and its functional significance.

Authors:  Eric Yung; Masha Sorin; Emilie-Jeanne Wang; Seena Perumal; David Ott; Ganjam V Kalpana
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

9.  Transcription start regions in the human genome are favored targets for MLV integration.

Authors:  Xiaolin Wu; Yuan Li; Bruce Crise; Shawn M Burgess
Journal:  Science       Date:  2003-06-13       Impact factor: 47.728

10.  Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences.

Authors:  Rick S Mitchell; Brett F Beitzel; Astrid R W Schroder; Paul Shinn; Huaming Chen; Charles C Berry; Joseph R Ecker; Frederic D Bushman
Journal:  PLoS Biol       Date:  2004-08-17       Impact factor: 8.029
View more
  19 in total

1.  Symmetrical recognition of cellular DNA target sequences during retroviral integration.

Authors:  Duane P Grandgenett
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-19       Impact factor: 11.205

2.  Retroviral vector integration deregulates gene expression but has no consequence on the biology and function of transplanted T cells.

Authors:  Alessandra Recchia; Chiara Bonini; Zulma Magnani; Fabrizia Urbinati; Daniela Sartori; Sara Muraro; Enrico Tagliafico; Attilio Bondanza; Maria Teresa Lupo Stanghellini; Massimo Bernardi; Alessandra Pescarollo; Fabio Ciceri; Claudio Bordignon; Fulvio Mavilio
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

3.  Proviruses selected for high and stable expression of transduced genes accumulate in broadly transcribed genome areas.

Authors:  Jirí Plachy; Jan Kotáb; Petr Divina; Markéta Reinisová; Filip Senigl; Jirí Hejnar
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

4.  SATB1-binding sequences and Alu-like motifs define a unique chromatin context in the vicinity of human immunodeficiency virus type 1 integration sites.

Authors:  Pavan P Kumar; Sameet Mehta; Prabhat Kumar Purbey; Dimple Notani; Ranveer S Jayani; Hemant J Purohit; Dhananjay V Raje; Dyavar S Ravi; Ramesh R Bhonde; Debashis Mitra; Sanjeev Galande
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

5.  Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome.

Authors:  Stephen D Barr; Jeremy Leipzig; Paul Shinn; Joe R Ecker; Frederic D Bushman
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

6.  Porcine endogenous retrovirus integration sites in the human genome: features in common with those of murine leukemia virus.

Authors:  Yann Moalic; Yannick Blanchard; Hélène Félix; André Jestin
Journal:  J Virol       Date:  2006-08-23       Impact factor: 5.103

7.  Integration target site selection by a resurrected human endogenous retrovirus.

Authors:  Troy Brady; Young Nam Lee; Keshet Ronen; Nirav Malani; Charles C Berry; Paul D Bieniasz; Frederic D Bushman
Journal:  Genes Dev       Date:  2009-03-01       Impact factor: 11.361

8.  The expression of exogenous genes in macrophages: obstacles and opportunities.

Authors:  Xia Zhang; Justin P Edwards; David M Mosser
Journal:  Methods Mol Biol       Date:  2009

9.  Methods for integration site distribution analyses in animal cell genomes.

Authors:  Angela Ciuffi; Keshet Ronen; Troy Brady; Nirav Malani; Gary Wang; Charles C Berry; Frederic D Bushman
Journal:  Methods       Date:  2008-11-25       Impact factor: 3.608

10.  Transcription factor binding sites are genetic determinants of retroviral integration in the human genome.

Authors:  Barbara Felice; Claudia Cattoglio; Davide Cittaro; Anna Testa; Annarita Miccio; Giuliana Ferrari; Lucilla Luzi; Alessandra Recchia; Fulvio Mavilio
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.